Fig. 1.
Fig. 1. Clinical extensive chronic GVHD after allogeneic blood stem cell transplantation. / The cumulative risk of chronic GVHD was 57% at 18 months. Patients surviving more than 1 year without chronic GVHD are indicated by the tick marks. Competing risks were relapse without chronic GVHD (cumulative incidence, 24%) and death without relapse or chronic GVHD (cumulative incidence, 4%).

Clinical extensive chronic GVHD after allogeneic blood stem cell transplantation.

The cumulative risk of chronic GVHD was 57% at 18 months. Patients surviving more than 1 year without chronic GVHD are indicated by the tick marks. Competing risks were relapse without chronic GVHD (cumulative incidence, 24%) and death without relapse or chronic GVHD (cumulative incidence, 4%).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal